Isabella Bondesson, CELLINK Tissue Engineer, will present her team's work on the development of skin tissue modes and the significant benefits they can bring to the cosmetic, pharmaceutical, and medical industries. She will also discuss the challenges the team faced and the solutions they came up with. Learning objectives: • Where to start and how to develop a skin model • Selecting the right biomaterials • Post bioprinting processes

In this session, we will review practices in 3D printing for reconstructive procedures from the perspective of an orthopedic surgeon.

In this session, a leading medical device expert will review the 510K process.

Take advantage of the AATB Organization Subscription and Single Sessions providing unlimited access to all staff for the entire year of educational programming

​Take advantage of the AATB Annual Subscription providing individual access to the entire year of educational programming With the Webinar Subscription Program, you can now have year-round access to subject matter experts and industry-leading education delivered right to your desk, conference room or smart phone.

This presentation will review updated to AATB Standards for Tissue Banking and NADO Standards as published in July, 2019.

This program will demonstrate best practices in the recovery of skin in a wet lab setting. This program will include core elements of skin recovery including mapping the skin donor, maintaining a 4” width of skin graft, monitoring thickness for processor specifications, best practices for difficult recovery sites, and the importance of the assistant. Please note: this program includes live-streamed video content that may not work on all devices. If you have trouble viewing the session, you can click the "Presentation Only" and then the "Presentation with Q & A" to participate in the question and answer segment.

In this session, we will review the fundamentals of CAPA.

In this session, a plastic surgeon who utilizes allograft skin in reconstructive procedures will present experiences and clinical cases which required allograft tissue.

In this presentation, Dr. Paymaun Lotfi, an orthopedic spine surgeon, will discuss the use of allografts in spine procedures. This session will include perspectives on the use of allograft tissue and case examples.

Annual Subscription Group

In a world of rapidly changing technology and expectations, every organization must address performance that includes adapting to the specifics of regulation and review while developing responsive approaches to both identify gaps and anticipate future needs. Recommendations will be provided for managing key performance indicators to identify gaps in performance and designing organizational project management approaches to create an organizational impetus to address many regulatory expectations and more rapid implementation. Key approaches to organizational level change management using project techniques and integration of performance improvement in education can lead to a grass-roots effort in the organization. A focus on performance and significant change provides a window to the future landscape of tissue recovery and processing and a door to organizational evolution.

Overtime we have seen the number of acceptable donors decrease due to the increase in “sepsis” in a donor medical chart. An examination of our screening process revealed that the way we asked questions, how we reviewed charts and changes that hospitals made when evaluating a patient for possible sepsis have been responsible for some of the decline in the numbers of acceptable donors. In the past a potential donor could be found unsuitable because the donor was reported to be septic or possibly septic or the COD was reported to be sepsis or probable sepsis at initial screening. Sometimes sepsis showed up in a physician note or a review of specific laboratory data which led us to believe that the patient was possibly septic. The challenge was to develop new screening processes to help identify those donors who may not actually be septic while at the same time ensuring that we work within the FDA and AATB regulations. Other organizations, like ourselves, have developed new processes for screening. Though the processes differ in their design and degree of simplicity their goal is the same which is to be able to identify with some degree of accuracy those donors who may not be septic at the time of death. Examples include changing how questions are asked at initial screening, using an algorithm when reviewing a medical chart and even eliminating the need for Call Center personnel to review laboratory data. Today we will go over some of the changes we made, review our algorithm and discuss the advantages and disadvantages to screening this way.

This presentation will demonstrate and review the basics of a forensic autopsy including; sample collection, dissection, physical findings and more.

This presentation will highlight past culture rates for Gift of Life Michigan, LifeShare Carolinas, and the Center for Organ Recovery and Education. It will show that there were opportunities for improvement, what those improvements were, and the current statistics of culture rates within these organizations.

Join Bioprinting Field Application Specialist Nicole Diamantides for a webinar on using 3D Bioprinting for COVID-19 research.

This presentation will review cases requiring the use of birth tissue presented by the surgeon.

This presentation will review a high level summary of various birth tissue processing methods and clinical applications.

The donation and acquisition of birth tissues present a number of technical hurdles to an OTPO that already recovers cadaveric tissue for transplantation. Birth Tissue A – Z will provide an overview of birth tissue program considerations and challenges. Focusing on the essential building blocks of a successful birth tissue program, we will review aspects of the birth tissue program that differ from traditional cadaveric tissue programs. The role of physicians and hospital staff will be discussed and we will provide insight surrounding the structure and typical challenges that an OTPO can encounter when implementing a birth tissue recovery program.

In this session, from an engineer’s perspective, Prof. Willett will define bone quality and how it relates to the mechanical performance of cortical bone allograft. He will discuss the variability in and degradation of bone quality, particularly those independent of clinical bone mineral density measures, resulting from donor characteristics and disease states, processing, sterilization and implantation. Specific attention will be paid to the effects of gamma irradiation sterilization, recent progress in protecting the mechanical performance of cortical bone while still using conventional gamma irradiation sterilization, and opportunities and challenges for bone quality assessment in tissue banking.

Brandon's mom shares his story life and giving the gift of life through organ and tissue donation.

This session recorded session was presented as a part of the 2020 Virtual QDEW .

In this session, we will review concepts of competency programs focusing on applied learning and measurable outcomes of training and education.

This session recording was presented as a part of the 2020 Virtual QDEW.

This session provides an overview of the cardiac tissue recovery process.

In this session, we will review current trends in marketing and clinical review of allografts.

This webinar will review current trends in surgical use and clinical application of cardiac and vascular allografts.

This program will review the chemical and physical properties of various regenerative materials to assist clinicians in selecting the best materials to meet the clinical need of the patient. A comprehensive review of the many types of tissue-based products and their clinical applications will be presented in case format to provide a working knowledge of the most optimal bone graft material or membrane for the defect to achieve an aesthetic and predictable outcome for the patient.

Recent publicized events of cryogenic storage tank failures have created nationwide concern among infertility patients and patients storing embryos and gametes for future use. To assure patient confidence, quality management (QM) plans applied by in vitro fertilization (IVF) laboratories need to include a more comprehensive focus on the cryostorage of reproductive specimens. The purpose of this review is to provide best practice guidelines for the cryogenic storage of sperm, oocytes, embryos, and other reproductive tissues (e.g., testicular and ovarian tissue, cord blood cells, and stem cells) and recommend a strategy of thorough and appropriate quality and risk management procedures aimed to alleviate or minimize the consequences from catastrophic events.

In this session, we will review basic concepts of grief and trauma with approaches to supporting families during such difficult times.

This session will walk attendees through the basics of cord blood donation, collection, research and more!

This program will evaluate the essential pieces of the Donor Risk Assessment Interview (DRAI) process and connect questions to their intent and underlying eligibility considerations.

This presentation will review the structure of coroner systems throughout the United States.

This session recording was presented as a part of the 2020 Virtual QDEW.

Versiti OPO/Tissue Bank will share their journey of developing their culture over the years and how resiliency has been a critical part of improving staff engagement and overall performance. Versiti will share the foundations of their resiliency culture, specific programs developed along the way, measurable impact, and plans for future expansion of the Resiliency Program.

Engaging out-of-hospital partners fosters a culture of donation throughout communities while providing mutually beneficial results. Learn more about working with law enforcement, hospice, coroners/medical examiner partners to increase donation opportunities and public outreach efforts.

This presentation will explain the collaboration process and system established for international tissue recovery training, its effectiveness and lessons learned. In 2013, the Ontario Ministry of Health and Long-Term Care wanted an integrated and effective tissue donation, banking, and transplant system for Ontario, and in 2017 tissue recovery was consolidated under Trillium Gift of Life Network (TGLN). The leadership team at TGLN had to develop a process to train all their recovery staff, this proved difficult due to very low donor numbers. TGLN decided that outsourcing training to an American OPO with higher donor numbers would be the most practical option for training and to learn best practices. LifeGift learned of the training opportunity and was selected as the OPO to train the TGLN recovery staff.

This presentation will review current infectious diseases, epidemics and geographically relevant communicable diseases.

In this session, we will review the process for developing and validating tissue processing equipment.

This presentation will review practices, challenges and case studies surrounding post valve donation pathological examination.

In May 2020, amid COVID-19, a major health pandemic, another critical world-changing event occurred in the tragic death of George Floyd. That moment changed the trajectory of our nation's conversation in how we potentially communicate with, value, and respect one another. It is also a moment where Black Lives Matter is the anthem of equity & justice in the collective voices of a multicultural generation. This conversation will frame this moment and deconstruct a few of the myths that continue to divide and harm black, brown, and indigenous bodies, and our collective humanity.

This presentation will strive to examine current official statements by various religious bodies and/or religious leaders regarding anatomical gift donation and discuss the disparity between corporately held beliefs and personal ones. In addition, this presentation will examine the challenges associated with interfacing with various religious bodies, such as language and symbolism and offer some suggestions moving forward.

Through this session, we will review key considerations in determining donor eligibility in death involving prescription and illicit drugs. In addition to the concern for RCDADs, we will evaluate implications on tissue quality and viability as a result of chronic and acute drug involvement and toxicity.

In this session, we will review methods of approaching discussions about donation what people ask, "What exactly do you do?"

The Donate Life America Funeral Services Committee and the Funeral Liaisons from LifeSource will be presenting embalming and restorative techniques post tissue recovery. The session will include practical and innovative ideas on the care of a tissue donor and necessary supplies to provide to the funeral home. You will also learn the importance of surgical technique during the recovery and how it can impact the embalming process. This session aims to share the concerns of the funeral service partners and ways to improve the relationship through education, training, and support.​

Contingency planning and emergency preparedness are critical to assuring the sustainability donation in the event of a tragedy or natural disaster. In this session, we will review organizational practices and experiences in developing a contingency or disaster plan.

Presentations often focus on the accomplishments of a single department, but what about the amazing work that is being done between departments within an organization or even between organizations? This presentation seeks to offer examples of cooperation between various departments/agencies by focusing on Family Services departments in three different organizations: Carolina Donor Services, Lions Eye Institute for Transplantation and Research and New England Donor Services. The objective of this presentation is to help participants identify opportunities for interdepartmental/interagency cooperation and encourage dialog both within and between organizations.

Through this session, Nevada Donor Network will present their challenges, experiences, and process in establishing a birth tissue acquisition program in their service area.

This presentation given by FDA ORA and CBER staff will provide information on what you can expect to occur during FDA inspections and how to prepare your staff and facility to be ready for FDA inspections. It will also include discussion of common observations (findings) and resulting compliance actions from FDA inspections conducted in the past couple of years.

In this session, we will review how one cardiac and vascular tissue establishment uses allografts unsuitable for transplant to train surgeons.